UID:
almahu_9949850817702882
Umfang:
VI, 193 p. 12 illus., 7 illus. in color.
,
online resource.
Ausgabe:
2nd ed. 2024.
ISBN:
9783031585722
Serie:
Advances in Microbiology, Infectious Diseases and Public Health, 1449
Inhalt:
This fully updated second edition demonstrates the major impact that the gut microbiota has on human gastrointestinal health, with a special focus on children. The book also explores the potential use of probiotic microorganisms to protect or improve gastrointestinal health in children. Humans are not a single organism: We are a multi-organic structure composed of ourselves and our microbiota, living in close symbiosis since birth and even before. The enormous impact that the billions of microscopic cells in our gut have on our gastrointestinal and systemic health cannot be overstated. The tremendous progress that has been made in the last decade in our still very incomplete understanding of the gut microbiota opens the door to potential applications in human health that were simply unthinkable before. One of the most interesting aspects of this new scientific horizon is the fact that we can identify (or even create in the lab) many of these "friendly bacteria" and use themto protect or improve our health. Thus, strains of probiotic microorganisms are being identified and studied in a variety of clinical scenarios. One of the most studied areas for probiotics is pediatric gastrointestinal health. Topics covered in this book range from the development of the intestinal microbiota in the fetus and neonate to current and potential applications in various conditions such as necrotizing enterocolitis or infectious or inflammatory diseases of the child. Written by an international group of preeminent experts in these fields in a rigorous, evidence-based manner, the book is intended for pediatric gastroenterologists, pediatricians, and medical scientists alike.
Anmerkung:
Shaping Microbiota during the first 1000 days of life -- Necrotizing Enterocolitis and the Preterm Infant Microbiome -- Can postbiotics represent a new strategy for NEC? -- Preventing And Treating Colic: An Update -- Targeting Food Allergy with Probiotics -- Probiotics to Prevent Celiac Disease and Inflammatory Bowel Disease -- Nutritional interventions, probiotics, synbiotics and fecal microbiota transplantation in steatotic liver disease -- Probiotics in the treatment of inflammatory bowel disease -- Acute Infectious Diarrhea -- Probiotics in functional gastrointestinal disorders -- Clostridioides difficile infections: Prevention and Treatment Strategies -- Current Regulatory Issues For The Use Of Probiotics.
In:
Springer Nature eBook
Weitere Ausg.:
Printed edition: ISBN 9783031585715
Weitere Ausg.:
Printed edition: ISBN 9783031585739
Weitere Ausg.:
Printed edition: ISBN 9783031585746
Sprache:
Englisch
DOI:
10.1007/978-3-031-58572-2
URL:
https://doi.org/10.1007/978-3-031-58572-2
Bookmarklink
